Positioning no disclosures inside 60 days, left as found
Options put/call open interest 3.04, read 2026-11-05
Ethical passes the values gate
Price68.94 USD
Fair value101.25
Ethical score70.0/100
Value readUndervaluedas of 6 Nov 2026
Our investment reviews on this name
2026-11-05Read Markup71.73-3.9% to today Markdown gives way to Markup first Markup read since July
2026-09-09Read Markdown70.04-1.6% to today ✓Distribution gives way to Markdown after a 7% slide in 5 weeks
2026-08-08Read Distribution74.91-8.0% to today ✓Markup gives way to Distribution after a 12% slide in 5 weeks
2026-07-02Read Markup85.16-19.0% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
PHINIA Inc. holds its Markup at $68.94. The statistical read favours the buyers, held for 45 days.
As held on the ledger · 2026-11-06
Phase
Markup
Quantitative state
The statistical read favours the buyers, held for 45 days
Price at the screen
$68.94
Valuation
14.55 trailing · 10.38 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.11
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
26.72%
Below 33%
Interest-bearing debt is just 26.7% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.13%
Below 33%
Cash held in interest-bearing accounts and securities is 0.1% of assets, under the one-third limit.
Pass
Receivables
25.67%
Below 49%
Money owed to the company is 25.7% of assets, under the 49% limit.
Pass
Revenue purity
0.40%
Below 5%
Only 0.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
PHINIA clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 27%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when PHIN's ethical verdict changes
Today PHIN passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 6 Nov 2026: it trades at roughly a 32% discount to our $101.25 fair value, 0.40% revenue growth.
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. A 31.9% discount to the base estimate.
Where our models see it going: fair-value estimate $101.25, with a range of $101.25 to $137.88, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Auto parts supplier looks cheap but stays unappealing
Picture a fuel pump or injector failing on a busy motorway and the whole supply chain feels the jolt. PHINIA makes those critical pieces for engines and the aftermarket, yet its 4% profit margin and 9% ROE show thin returns even as revenue edges up 10%. The forward multiple of 11.8 times sits well below our fair value of 105 dollars from the current 80 dollars, yet the opportunity rating stays at none.
The business clears the ethical screen and five analysts call the shares a buy with a 95 dollar median target. Still the unknown moat and the fact this sits in a deeply cyclical corner of autos keep us on the sidelines. Low multiples in this sector often signal peak earnings rather than a bargain.
Currency swings, shifting EV demand and thin cash conversion add real downside that the headline numbers do not capture. We see no reason to step in now.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
PHIN trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Markup · changed$71.73+24.4%Entry 17
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 24.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 86%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $89.
2026-10-29Markdown$57.68+0.9%Entry 16
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 86%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $89. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Markdown$57.17+0.0%Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 86%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $89. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Markdown$57.17+0.0%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 86%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $89. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Markdown$57.17+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 86%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $89. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markdown$57.17+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 86%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $89. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Markdown$57.17+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 86%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $89. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markdown$57.17+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 86%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $89. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markdown$57.17-1.0%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 86%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $89. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Markdown$57.75-0.1%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 86%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (4 analysts) rates it none, with a mean price target of $89.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
